ADAP
Adaptimmune Therapeutics
ADAP
ADAP
79 hedge funds and large institutions have $1.03B invested in Adaptimmune Therapeutics in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 20 closing their positions.
Holders
79
Holders Change
+2
Holders Change %
+2.6%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
23
Increased
23
Reduced
19
Closed
20
Calls
$2.02M
Puts
$1.04M
Net Calls
+$985K
Net Calls Change
+$6.21M